| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 1,782 | 1,278 | +39.4% |
| EBITDA | 249 | 124 | +101.2% |
| EBITDA margin | 14.0% | 9.7% | +4.3 pts |
| Profit before tax | 207 | 99.2 | +108.9% |
| Net profit | 166 | 79.5 | +108.7% |
| EPS | ₹46.80 | ₹22.42 | +108.7% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 7,692 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 582 | 582 | 492 | 418 | 232 | ||
| 164 | 164 | 142 | 132 | 272 | ||
| 7,274 | — | — | — | — | ||
| 5,752 | 5,248 | 4,224 | 3,794 | 4,445 | ||
| — | +24.3% | +11.3% | −14.6% | — | ||
| 601 | 475 | 484 | 462 | 568 | ||
| 10.4% | 9.1% | 11.5% | 12.2% | 12.8% | ||
| 471 | 352 | 374 | 362 | 485 | ||
| 354 | 267 | 305 | 301 | 381 | ||
| 6.2% | 5.1% | 7.2% | 8.0% | 8.6% | ||
| ₹99.81 | ₹75.42 | ₹86.01 | ₹85.04 | ₹107.47 | ||
| — | −12.3% | +1.1% | −20.9% | — | ||
| — | 333 | 421 | 518 | 573 | ||
| — | −137 | −219 | −158 | −146 | ||
| 196 | 196 | 202 | 360 | 427 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 7,691.6 | |
| - Cash, Equiv & ST Investments | 231.9 | 418.5 | 491.9 | 581.8 | 581.8 | |
| + Total Debt | 271.8 | 131.7 | 141.8 | 164.5 | 164.5 | |
| Enterprise Value | — | — | — | — | 7,274.3 | |
| Revenue | 4,445.2 | 3,794.4 | 4,223.7 | 5,248.3 | 5,752.3 | |
| Growth %, YoY | — | -14.6 | +11.3 | +24.3 | — | |
| EBITDA | 568.3 | 462.2 | 484.2 | 475.3 | 600.7 | |
| Margin % | 12.78 | 12.18 | 11.46 | 9.06 | 10.44 | |
| EBIT | 484.8 | 362.4 | 373.9 | 352.3 | 471.0 | |
| Net Income | 381.0 | 301.5 | 304.9 | 267.4 | 353.8 | |
| Margin % | 8.57 | 7.95 | 7.22 | 5.09 | 6.15 | |
| EPS, Adj (current shares) | 107.47 | 85.04 | 86.01 | 75.42 | 99.81 | |
| Growth %, YoY | — | -20.9 | +1.1 | -12.3 | — | |
| Cash from Operations | 573.0 | 518.4 | 420.5 | 332.7 | — | |
| Capital Expenditures | -146.1 | -158.3 | -218.7 | -137.0 | — | |
| Free Cash Flow | 426.9 | 360.2 | 201.9 | 195.7 | 195.7 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Galaxy Surfactants (NSE: GALAXYSURF) had a market capitalisation of ₹7,703 crore at the 29 October 2026 close (₹2,172.80 a share), a PE ratio of 21.8 on the last four quarters' profit and a price-to-book ratio of 2.81. In FY26 its consolidated net profit was ₹267 crore on revenue of ₹5,248 crore; in Q1 FY27 (April–June 2026) it was ₹166 crore, up 108.7% year on year. Its debt-to-equity ratio was 0.06 on 31 March 2026. Promoters held 70.90% of the shares on 30 September 2026.
Galaxy Surfactants' PE ratio is 21.8 at the 29 October 2026 close (₹2,172.80 a share): a market capitalisation of ₹7,703 crore divided by consolidated net profit of ₹354 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹267 crore) it is 28.8.
No. Galaxy Surfactants had borrowings of ₹164 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.06. Its cash and current investments were ₹748 crore, so it held net cash of ₹583 crore.
Galaxy Surfactants' debt-to-equity ratio was 0.06 on 31 March 2026: borrowings of ₹164 crore against total equity of ₹2,745 crore. A year earlier, on 31 March 2025, it was 0.06.
Galaxy Surfactants' price-to-book (PB) ratio is 2.81 at the 29 October 2026 close: a market capitalisation of ₹7,703 crore divided by shareholders' equity (book value) of ₹2,745 crore on 31 March 2026. That is a book value of ₹774.28 per share against a share price of ₹2,172.80.
Galaxy Surfactants' net worth — shareholders' equity in its consolidated balance sheet — was ₹2,745 crore on 31 March 2026, up 16.2% from ₹2,363 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹7,703 crore at the 29 October 2026 close.
In FY26, Galaxy Surfactants' return on equity (ROE) was 10.5% and its return on capital employed (ROCE) was 13.2%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 13.4% and ROCE 15.6%.
Galaxy Surfactants' market capitalisation was ₹7,703 crore at the 29 October 2026 close: 3.55 crore shares at ₹2,172.80 each.
Galaxy Surfactants' basic earnings per share (EPS) were ₹75.41 in FY26, against ₹86.00 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹99.78.
In 2026, Galaxy Surfactants has declared one dividend: ₹22 with record date 31 July 2026.
Galaxy Surfactants' book value per share was ₹774.28 on 31 March 2026: shareholders' equity of ₹2,745 crore divided by the 3.55 crore shares in issue, up 16.2% from ₹666.44 a year earlier. The share price at the 29 October 2026 close was ₹2,172.80.
Galaxy Surfactants' latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹166 crore, up 108.7% from ₹79.5 crore in Q1 FY26; revenue from operations ₹1,782 crore, up 39.4% year on year.
In FY26 (April 2025–March 2026), Galaxy Surfactants' consolidated net profit was ₹267 crore, down 12.3% from ₹305 crore in FY25, on revenue from operations of ₹5,248 crore (up 24.3%). Over three years, from FY23, net profit was down 29.8%.
Galaxy Surfactants' dividend yield is 1.01% at the 29 October 2026 close: dividends of ₹22 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹2,172.80. They were ₹22 on 31 July 2026.
Promoters held 70.90% of Galaxy Surfactants on 30 September 2026, unchanged from the previous quarter and down 0.01 percentage points from 70.91% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Galaxy Surfactants generated ₹333 crore of cash from operations and spent ₹137 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹196 crore. In FY25 it was ₹202 crore.
On 30 September 2026, Galaxy Surfactants' shares were held by promoters 70.90%, foreign portfolio investors (FII/FPI) 3.94%, domestic institutions (DII) 13.12% (including mutual funds at 11.77%) and retail and other non-institutional investors 12.03%. Over the year, FII holding was down 0.28 percentage points from 4.22% and DII holding was up 0.22 percentage points from 12.90%.
On FY26 consolidated figures, against Linde India, Gujarat Fluorochemicals and Fineotex Chemical: Galaxy Surfactants' operating margin of 6.7% is the lowest of the four (Linde India 26.6%, Gujarat Fluorochemicals 18.5%, Fineotex Chemical 15.7%; peer average 20.3%); its return on equity of 10.5% is the third highest of the four (Linde India 13.6%, Gujarat Fluorochemicals 7.7%, Fineotex Chemical 13.5%; peer average 11.6%).
At the 29 October 2026 closing prices, on FY26 net profit, Galaxy Surfactants' PE ratio is 28.8, the lowest of the four: Linde India 88.8, Gujarat Fluorochemicals 81.5 and Fineotex Chemical 54.8, a peer average of 75.0. Each is the company's market capitalisation at that price divided by its FY26 net profit.
Galaxy Surfactants will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
In FY26, Galaxy Surfactants earned net profit of ₹267 crore on revenue of ₹5,248 crore, against ₹549 crore on ₹2,531 crore for Linde India. Galaxy Surfactants' operating margin was 6.7% (Linde India 26.6%) and its return on equity 10.5% (Linde India 13.6%). At the 29 October 2026 close, Galaxy Surfactants' market capitalisation was ₹7,703 crore against ₹48,765 crore for Linde India, and its PE ratio on FY26 profit 28.8 against 88.8.
From Galaxy Surfactants' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.